These studies demonstrated that the genetic deletion of NLRP3 dampened the progression of renal disease, but did not differentiate whether the protective effect originates from the depletion of inflammasome-dependent NLRP3 in innate immune cells or inflammasome-independent NLRP3 in resident renal cells. This evidence concerns the gene NLRP3 and kidney disorder.